Over the past 12 months, 0 insiders at ALPINE IMMUNE SCIENCES, INC. filed 0 open-market SEC Form 4 transactions on ALPN: 0 purchases worth $0 and 0 sales worth $0. Insiders have been mixed over this period. The most recent filing was on .
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Apr 25, 24 | James N TopperDirector | SELL | 19 | $64.57 | $1K |
| Jan 26, 24 | James Paul RickeySee Remarks | SELL | 73.8K | $25.00 | $1.6M |
| Jan 25, 24 | James Paul RickeySee Remarks | SELL | 236 | $22.00 | $5K |
| Dec 28, 23 | Mitchell GoldExecutive Chairman and CEO | SELL | 1.0K | $20.04 | $20K |
| Dec 28, 23 | Orbimed Genesis Gp LlcDirector | SELL | 1.20M | $19.82 | $21.9M |
| Dec 28, 23 | Peter A. ThompsonDirector | SELL | 1.20M | $19.82 | $21.9M |
| Dec 27, 23 | Orbimed Genesis Gp LlcDirector | SELL | 162.6K | $19.96 | $3.2M |
| Dec 27, 23 | Peter A. ThompsonDirector | SELL | 162.6K | $19.96 | $3.2M |
| Dec 27, 23 | Mitchell GoldExecutive Chairman and CEO | SELL | 29.6K | $20.04 | $593K |
| Dec 26, 23 | Mitchell GoldExecutive Chairman and CEO | SELL | 24.5K | $20.22 | $495K |
| Dec 22, 23 | Mitchell GoldExecutive Chairman and CEO | SELL | 37.8K | $20.43 | $773K |
| Dec 19, 23 | Mitchell GoldExecutive Chairman and CEO | SELL | 2.4K | $20.01 | $48K |
| Dec 19, 23 | James Paul RickeySee Remarks | SELL | 15.2K | $19.21 | $292K |
| Dec 18, 23 | James Paul RickeySee Remarks | SELL | 1.8K | $19.00 | $34K |
| Dec 15, 23 | James Paul RickeySee Remarks | SELL | 45.4K | $19.09 | $866K |
| Dec 14, 23 | James Paul RickeySee Remarks | SELL | 11.6K | $19.00 | $220K |
| Dec 12, 23 | Mitchell GoldExecutive Chairman and CEO | SELL | 32.5K | $17.32 | $562K |
| Dec 11, 23 | Mitchell GoldExecutive Chairman and CEO | SELL | 68.9K | $17.26 | $1.2M |
| Dec 8, 23 | Mitchell GoldExecutive Chairman and CEO | SELL | 8.1K | $17.08 | $138K |
| Dec 6, 23 | James Paul RickeySee Remarks | SELL | 6.4K | $16.08 | $104K |
| Dec 5, 23 | James Paul RickeySee Remarks | SELL | 418 | $16.01 | $7K |
| Dec 4, 23 | James Paul RickeySee Remarks | SELL | 63.9K | $16.06 | $1.0M |
| Nov 30, 23 | James Paul RickeySee Remarks | SELL | 700 | $16.00 | $11K |
| Nov 9, 23 | Xiangmin CuiDirector,TenPercentOwner | BUY | 375.0K | $12.50 | $4.7M |
| Nov 9, 23 | Decheng Capital Global Healthcare Fund (master), LpTenPercentOwner | BUY | 375.0K | $12.50 | $4.7M |
| Nov 6, 23 | James Paul RickeySee Remarks | SELL | 18.0K | $16.03 | $289K |
| Feb 11, 22 | L.p. Fhm Life Sciences ViiiTenPercentOwner | BUY | 112.7K | $7.10 | $800K |
| Dec 31, 21 | James Paul RickeySenior VP and CFO | SELL | 17.0K | $13.92 | $237K |
| Sep 23, 21 | Robert E ConwayDirector | BUY | 15.0K | $10.08 | $151K |
| Sep 23, 21 | Robert E ConwayDirector | SELL | 15.0K | $10.08 | $151K |
| Sep 23, 21 | Christopher PeetzDirector | BUY | 1.9K | $10.17 | $19K |
| Sep 23, 21 | Christopher PeetzDirector | SELL | 1.9K | $10.17 | $19K |
| Sep 21, 21 | Robert E ConwayDirector | BUY | 10.0K | $9.80 | $98K |
| Sep 17, 21 | Alpine Bioventures, Gp, LlcTenPercentOwner | SELL | 400.0K | $9.40 | $3.8M |
| Sep 17, 21 | Xiangmin CuiDirector,TenPercentOwner | BUY | 1.54M | $9.40 | $14.5M |
| Sep 17, 21 | Decheng Capital Management III (cayman), LlcTenPercentOwner | BUY | 1.54M | $9.40 | $14.5M |
| Sep 17, 21 | Mitchell GoldExecutive Chairman and CEO | SELL | 400.0K | $10.01 | $3.8M |
| Sep 17, 21 | Orbimed Advisors LlcDirector,TenPercentOwner | BUY | 585.1K | $9.40 | $5.5M |
| Sep 17, 21 | Peter A. ThompsonDirector,TenPercentOwner | BUY | 585.1K | $9.40 | $5.5M |
| Sep 17, 21 | Jay VenkatesanDirector,TenPercentOwner | SELL | 400.0K | $9.40 | $3.8M |
| Sep 16, 21 | Mitchell GoldExecutive Chairman and CEO | SELL | 6.8K | $10.00 | $68K |
| Sep 15, 21 | Mitchell GoldExecutive Chairman and CEO | SELL | 3.5K | $10.00 | $35K |
Over the past 12 months, insiders at ALPINE IMMUNE SCIENCES, INC. filed 0 open-market purchases worth $0 and 0 sales worth $0 on ALPN, which makes them mixed over the period. The most recent Form 4 was filed on .
The largest recent open-market ALPN insider purchase in our data was $14.5M by Xiangmin Cui, Director,TenPercentOwner, filed on Sep 17, 21.
0 different insiders at ALPINE IMMUNE SCIENCES, INC. filed open-market SEC Form 4 transactions on ALPN over the last 12 months.
InsiderTape plots every ALPN insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every ALPINE IMMUNE SCIENCES, INC. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →